Cited by 211Antifungal resistance and susceptibilityBacterial Identification and Susceptibility TestingYeasts and Rust Fungi Studies

Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents

Open access
Barry, A. L., Pfaller, M. A., Brown, S. D., Espinel-Ingroff, A., Ghannoum, M. A., Knapp, C., Rennie, R. P., Rex, J. H. +1 more·2000·Journal of Clinical Microbiology

Abstract

Broth microdilution susceptibility tests of Candida species have now been standardized by the National Committee for Clinical Laboratory Standards (NCCLS). An eight-laboratory collaborative study was carried out in order to document reproducibility of tests of Candida parapsilosis ATCC 22019 and Candida krusei ATCC 6258 by the NCCLS method. Replicate broth microdilution tests were used to define control limits for 24- and 48-h MICs of amphotericin B, flucytosine, fluconazole, voriconazole, ketoconazole, itraconazole, caspofungin (MK 0991), ravuconazole (BMS 207147), posaconazole (SCH 56592), and LY 303366.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jcm.38.9.3457-3459.2000

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • For the five molds and the yeast isolate, >99% of the inocula were within the target ranges (0.4 × 10^6 to 5 × 10^6 CFU/ml for molds and 1 × 10^6 to 5 × 10^6 CFU/ml for C. krusei).

    “for the five molds and the yeast isolate, >99% of the inocula were within the target ranges (0.4 × 106 to 5 × 106 CFU/ml [molds] and 1 × 106 to 5 × 106 CFU/ml[C. krusei]) or similar reproducibility as in previous collaborative studies (92 to 95%) (1, 2, 7, 8).”

    From Quality Control Guidelines for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole Disk Diffusion Susceptibility Tests with Nonsupplemented Mueller-Hinton Agar (CLSI M51-A Document) for Nondermatophyte Filamentous Fungi (2011) · cites this paper as [1]

    The paper’s inoculum-density passage (page not specified in the indexed copy) reports testing two yeast control strains, not five molds and one yeast. For C. krusei, it reports counts of 0.2 × 10³ to 2.5 × 10³ CFU/ml after inoculation, contrary to the claimed range of 1 × 10⁶ to 5 × 10⁶ CFU/ml; it does not report the claimed >99% figure. (LLM, conf=0.84)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 10 · Cited by 211

Authors
Barry, A. L., Pfaller, M. A., Brown, S. D., Espinel-Ingroff, A., Ghannoum, M. A., Knapp, C., Rennie, R. P., Rex, J. H., & Rinaldi, M. G.
Affiliations
  • The Clinical Microbiology Institute, Wilsonville, Oregon 1 ;
  • University of Iowa (US)
  • Virginia Commonwealth University (US)
  • University Center Reference Laboratory for Medical Mycology, Cleveland, Ohio 4 ;
  • Trek Diagnostic Systems, Inc., Westlake, Ohio 5 ;
  • National Center for Mycology, Edmonton, Alberta, Canada 6 ; and
  • The University of Texas Health Science Center at Houston (US)
  • The University of Texas at San Antonio Health Science Center (US)
Venue
Journal of Clinical Microbiology
Published
2000
Volume
38
Issue
9
Pages
3457-3459
ISSN
  • 0095-1137 (ISSN-L)
  • 1098-660X
OpenAlex
W1774456129
Cited by
211
References
10
Citations by year
2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 5 · 2019: 1 · 2017: 2 · 2016: 5 · 2015: 6 · 2014: 4 · 2013: 2 · 2012: 5
FWCI
15.70
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Microbiology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Bacterial Identification and Susceptibility Testing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
Keywords
quality control limits, broth microdilution, antifungal susceptibility testing, Candida parapsilosis, Candida krusei, reproducibility, minimum inhibitory concentration, amphotericin B, 5-fluorocytosine, fluconazole, voriconazole, ketoconazole, itraconazole, caspofungin, ravuconazole, posaconazole, antifungal agents
MeSH terms
Antifungal Agents, Candida, Laboratories, Microbial Sensitivity Tests, Quality Control, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review